课题基金 / 基金详情

Realignment of a 600 MHz NMR system for cellular applications and antibiotic development

Realignment of a 600 MHz NMR system for cellular applications and antibiotic development
重新调整 600 MHz NMR 系统,用于细胞应用和抗生素开发
批准号:
497967936
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Major Research Instrumentation
财政年份:
2022
资助国家:
德国
项目状态:
未结题
起止时间:
2021-12-31 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The main goal of the project is to make the outstanding properties of fluorine atoms (19F) available for NMR-based structural investigations for the research groups at HHU. The measure therefore represents an essential application extension of the Biomolecular NMR Center, which has been in existence since 2004, and will enable high-resolution insights into cellular systems as well as significantly more efficient antibiotic development. Currently, there is no adequate possibility at HHU to use 19F nuclear spins in biological macromolecules and in living systems. However, a steadily growing body of research from other NMR centers confirms the broad applicability and tremendous scientific utility of 19F nuclear spin. The real benefit of the 19F detection technique stems from the fact that fluorine atoms, on the one hand, have very good NMR properties (100% occurrence of the NMR active isotope, high signal strength and strong dependence of the NMR frequency on the chemical environment). Furthermore, 19F is present only in negligible amounts in biological systems, such as eukaryotic cells. However, there are numerous ways to specifically label molecules with 19F. This allows, for example, highly sensitive and high-resolution NMR studies of 19F-labeled molecules of their native cellular environment, since virtually no background signal emanates from the cell. This is not the case for the regular NMR active nuclei of biological systems (1H, 13C, 15N, 31P). Therefore, concrete planned 19F-NMR applications include the investigation of the structure and dynamics of neuropeptides, G-protein coupled receptors, and DNA-mediated catalysis using so-called in-cell NMR methods. In addition, in-cell NMR will be further developed by using not only isolated cells but also, for the first time, so-called three-dimensional organoids, such as brain organoids.In addition to in-cell NMR, 19F NMR spectroscopy also offers unique possibilities for in vitro investigations, such as the characterization of nucleic acid structures or the screening of protein-ligand interactions. For the latter, an automated sample changer is also to be acquired as part of the measure, which should enable efficient screening of substance (fragment) e.g. for the development of a new class of antibiotics. The new in-cell NMR capabilities can be ideally combined with cryo-electron tomography. The planned combination of in-cell NMR and cryo-electron tomography will generate an outstanding added value for both foci of HHU, which is only available at a few locations worldwide.This measure is a new procurement that will serve to convert an already existing and fully intact 14.1 Tesla superconducting 600 MHz NMR magnet into a contemporary tool for in-cell and in-organoid NMR that is useful for the site.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
BRAF V600E突变型结直肠癌的免疫逃逸机制研究
  • 批准号:
    2025JJ40080
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    韩莹
  • 依托单位:
基于AI的甲状腺乳头状癌BRAFV600E基因突变和复发风险模型研究
  • 批准号:
    JCZRLH202500640
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
靶向BRAF V600E激酶分子胶降解剂的设 计合成及其作用机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    黎盛荣
  • 依托单位:
靶向PLK1通过铁死亡途径逆转BRAFV600E结直肠癌对BRAF和EGFR抑制剂耐药的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    潘京华
  • 依托单位: